These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers. Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kominami G; Kita T J Cardiol; 2010 Sep; 56(2):159-65. PubMed ID: 20605699 [TBL] [Abstract][Full Text] [Related]
5. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Hayashida K; Kume N; Murase T; Minami M; Nakagawa D; Inada T; Tanaka M; Ueda A; Kominami G; Kambara H; Kimura T; Kita T Circulation; 2005 Aug; 112(6):812-8. PubMed ID: 16061745 [TBL] [Abstract][Full Text] [Related]
6. Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome. Kook H; Jang DH; Kim JH; Cho JY; Joo HJ; Cho SA; Park JH; Hong SJ; Yu CW; Lim DS Sci Rep; 2020 Nov; 10(1):20228. PubMed ID: 33214686 [TBL] [Abstract][Full Text] [Related]
7. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study. Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kita T Circ J; 2010 Jul; 74(7):1399-404. PubMed ID: 20467154 [TBL] [Abstract][Full Text] [Related]
8. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease. Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905 [TBL] [Abstract][Full Text] [Related]
9. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound. Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography. Li QX; Fu QQ; Shi SW; Wang YF; Xie JJ; Yu X; Cheng X; Liao YH Heart; 2010 Feb; 96(3):196-201. PubMed ID: 19875365 [TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage. Kume N; Mitsuoka H; Hayashida K; Tanaka M J Cardiol; 2011 Jul; 58(1):38-45. PubMed ID: 21616640 [TBL] [Abstract][Full Text] [Related]
12. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. Tian J; Ren X; Vergallo R; Xing L; Yu H; Jia H; Soeda T; McNulty I; Hu S; Lee H; Yu B; Jang IK J Am Coll Cardiol; 2014 Jun; 63(21):2209-16. PubMed ID: 24632266 [TBL] [Abstract][Full Text] [Related]
13. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions]. Zhong Y; Ye F; You W; Wu ZM Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484 [No Abstract] [Full Text] [Related]
14. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein. Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872 [TBL] [Abstract][Full Text] [Related]
15. Thin-cap fibroatheroma as high-risk plaque for microvascular obstruction in patients with acute coronary syndrome. Ozaki Y; Tanaka A; Tanimoto T; Kitabata H; Kashiwagi M; Kubo T; Takarada S; Ishibashi K; Komukai K; Ino Y; Hirata K; Mizukoshi M; Imanishi T; Akasaka T Circ Cardiovasc Imaging; 2011 Nov; 4(6):620-7. PubMed ID: 21946700 [TBL] [Abstract][Full Text] [Related]
16. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay. Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802 [TBL] [Abstract][Full Text] [Related]
17. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease. Kamezaki F; Yamashita K; Tasaki H; Kume N; Mitsuoka H; Kita T; Adachi T; Otsuji Y Int J Cardiol; 2009 May; 134(2):285-7. PubMed ID: 18367271 [TBL] [Abstract][Full Text] [Related]
18. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study. Vergallo R; Ren X; Yonetsu T; Kato K; Uemura S; Yu B; Jia H; Abtahian F; Aguirre AD; Tian J; Hu S; Soeda T; Lee H; McNulty I; Park SJ; Jang Y; Prasad A; Lee S; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK Am Heart J; 2014 Jan; 167(1):59-67. PubMed ID: 24332143 [TBL] [Abstract][Full Text] [Related]
19. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome. Wang XH; Liu SQ; Wang YL; Jin Y Genet Mol Res; 2014 Jun; 13(2):4260-6. PubMed ID: 25036169 [TBL] [Abstract][Full Text] [Related]
20. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome. Lee T; Murai T; Isobe M; Kakuta T Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]